Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Dualistic function of Daxx at centromeric and pericentromeric heterochromatin in normal and stress conditions.

Morozov VM, Gavrilova EV, Ogryzko VV, Ishov AM.

Nucleus. 2012 May-Jun;3(3):276-85. doi: 10.4161/nucl.20180. Epub 2012 May 1.

2.

Erwin Schroedinger, Francis Crick and epigenetic stability.

Ogryzko VV.

Biol Direct. 2008 Apr 17;3:15. doi: 10.1186/1745-6150-3-15.

3.

Coactivators p300 and PCAF physically and functionally interact with the foamy viral trans-activator.

Bannert H, Muranyi W, Ogryzko VV, Nakatani Y, Fl├╝gel RM.

BMC Mol Biol. 2004 Sep 6;5:16.

4.

Chromatin dynamics and DNA repair.

Ikura T, Ogryzko VV.

Front Biosci. 2003 Jan 1;8:s149-55. Review.

PMID:
12456295
5.

Ssdp proteins interact with the LIM-domain-binding protein Ldb1 to regulate development.

Chen L, Segal D, Hukriede NA, Podtelejnikov AV, Bayarsaihan D, Kennison JA, Ogryzko VV, Dawid IB, Westphal H.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14320-5. Epub 2002 Oct 15.

6.

Metastable macromolecular complexes containing high mobility group nucleosome-binding chromosomal proteins in HeLa nuclei.

Lim JH, Bustin M, Ogryzko VV, Postnikov YV.

J Biol Chem. 2002 Jun 7;277(23):20774-82. Epub 2002 Mar 21.

7.

Mammalian histone acetyltransferases and their complexes.

Ogryzko VV.

Cell Mol Life Sci. 2001 May;58(5-6):683-92. Review.

PMID:
11437230
8.

Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis.

Ikura T, Ogryzko VV, Grigoriev M, Groisman R, Wang J, Horikoshi M, Scully R, Qin J, Nakatani Y.

Cell. 2000 Aug 18;102(4):463-73.

10.

An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression.

Rubinstein YR, Driggers PH, Ogryzko VV, Thornton AM, Ozato K, Pontzer CH.

Oncogene. 2000 Mar 9;19(11):1411-8.

11.

PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner.

Jiang H, Lu H, Schiltz RL, Pise-Masison CA, Ogryzko VV, Nakatani Y, Brady JN.

Mol Cell Biol. 1999 Dec;19(12):8136-45. Erratum in: Mol Cell Biol 2000 Mar;20(5):1897.

12.

TBP-associated factors in the PCAF histone acetylase complex.

Kotani T, Zhang X, Schiltz RL, Ogryzko VV, Howard T, Swanson MJ, Vassilev A, Zhang H, Yamauchi J, Howard BH, Qin J, Nakatani Y.

Cold Spring Harb Symp Quant Biol. 1998;63:493-9. Review. No abstract available.

PMID:
10384313
13.

Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo.

Li Q, Herrler M, Landsberger N, Kaludov N, Ogryzko VV, Nakatani Y, Wolffe AP.

EMBO J. 1998 Nov 2;17(21):6300-15.

14.

Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat.

Benkirane M, Chun RF, Xiao H, Ogryzko VV, Howard BH, Nakatani Y, Jeang KT.

J Biol Chem. 1998 Sep 18;273(38):24898-905.

15.

Histone-like TAFs within the PCAF histone acetylase complex.

Ogryzko VV, Kotani T, Zhang X, Schiltz RL, Howard T, Yang XJ, Howard BH, Qin J, Nakatani Y.

Cell. 1998 Jul 10;94(1):35-44.

16.

Differential roles of p300 and PCAF acetyltransferases in muscle differentiation.

Puri PL, Sartorelli V, Yang XJ, Hamamori Y, Ogryzko VV, Howard BH, Kedes L, Wang JY, Graessmann A, Nakatani Y, Levrero M.

Mol Cell. 1997 Dec;1(1):35-45.

17.

A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells.

Minucci S, Horn V, Bhattacharyya N, Russanova V, Ogryzko VV, Gabriele L, Howard BH, Ozato K.

Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11295-300.

18.

Acetylation of general transcription factors by histone acetyltransferases.

Imhof A, Yang XJ, Ogryzko VV, Nakatani Y, Wolffe AP, Ge H.

Curr Biol. 1997 Sep 1;7(9):689-92. Review.

19.

Antisense inhibition of CAS, the human homologue of the yeast chromosome segregation gene CSE1, interferes with mitosis in HeLa cells.

Ogryzko VV, Brinkmann E, Howard BH, Pastan I, Brinkmann U.

Biochemistry. 1997 Aug 5;36(31):9493-500.

PMID:
9235994
20.

WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases.

Ogryzko VV, Wong P, Howard BH.

Mol Cell Biol. 1997 Aug;17(8):4877-82.

21.
22.

A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.

Thornton AM, Ogryzko VV, Dent A, Sharf R, Levi BZ, Kanno Y, Staudt LM, Howard BH, Ozato K.

J Immunol. 1996 Dec 1;157(11):5145-54. Erratum in: J Immunol 1999 Mar 1;162(5):3103.

PMID:
8943426
23.

The transcriptional coactivators p300 and CBP are histone acetyltransferases.

Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y.

Cell. 1996 Nov 29;87(5):953-9.

24.

Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent.

Ogryzko VV, Hirai TH, Russanova VR, Barbie DA, Howard BH.

Mol Cell Biol. 1996 Sep;16(9):5210-8.

25.

A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.

Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y.

Nature. 1996 Jul 25;382(6589):319-24.

PMID:
8684459
26.

RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells.

Horn V, Minucci S, Ogryzko VV, Adamson ED, Howard BH, Levin AA, Ozato K.

FASEB J. 1996 Jul;10(9):1071-7.

PMID:
8801169
27.

Dissociation of retinoblastoma gene protein hyperphosphorylation and commitment to enter S phase.

Ogryzko VV, Hirai TH, Shih CE, Howard BH.

J Virol. 1994 Jun;68(6):3724-32.

Supplemental Content

Loading ...
Support Center